 Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Baricitinib for Sale > Baricitinib 100.4%

Baricitinib 100.4%

Name: Baricitinib 100.4%
Brand: HyperChem
SKU: pr2411061265
Price: 10 USD
Availability: InStock

TDS 9 Inquiries

Unit Price: Get Latest Price 

CAS No.:

1187594-09-7

Grade:

Pharmaceutical Grade

Content:

100.4%

Port:

HANGZHOU

Brand:

HyperChem

Packaging:

/Ctn

Price valid (until):

2024-12-06

Contact Supplier

 Chat Now

Hangzhou Hyper Chemicals Limited

Company Type:

Trader

Location:

China

Qualification:

Main Products:

Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

 Visit Store

Product Description
Seller Information
Inquiry History

Description

Name	Baricitinib
CAS number	1187594-09-7
Synonym	INCB028050; INCB-028050; INCB 028050; LY3009104; LY-3009104; LY 3009104; Baricitinib; Olumiant
Description	Baricitinib, also known as INCB028050 or LY3009104, is a selective orally bioavailable JAK1/JAK2 inhibitor with nanomolar potency against JAK1 (5.9 nM) and JAK2 (5.7 nM). INCB028050 inhibits intracellular signaling of multiple proinflammatory cytokines including IL-6 and IL-23 at concentrations <50 nM. INCB028050 was also effective in multiple murine models of arthritis, with no evidence of suppression of humoral immunity or adverse hematologic effects. Baricitinib was approved for the treatment of rheumatoid arthritis (RA) in the United States.
Structure
Molecular Formula	C16H17N7O2S
Molecular Weight	371.417
Appearance	white solid powder
Quality Standard	In-House
Shipping Condition	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition	Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Shelf Life	>2 years if stored properly
Sample package	Aluminium foil bag
Commercial package	Fiber ctn
Origin	China

ECHEMI Editorial Reference

The oral, targeted synthetic DMARD (tsDMARD), JAK1 and JAK2 inhibitor baricitinib (Olumiant) is a novel small molecule[1] that is approved in the EU and Japan for the treatment of adults with rheumatoid arthritis RA (moderate or severe active), who responded inadequately to (other treatments) or who were intolerant of C1 DMARD. JAK is a tyrosine kinase that plays crucial roles in cytokine receptor binding.

Certificates

Basic Info

Product Name:

Baricitinib

Other Name:

3-Azetidineacetonitrile,1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-;1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile;LY 3009104;Baricitinib;INCB 028050;INCB 28050;Olumiant;2-(3-(4-(3H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile;1231199-29-3;1374987-77-5

CAS No.:

1187594-09-7

Molecular Formula:

C16H17N7O2S

InChIKeys:

InChIKey=XUZMWHLSFXCVMG-UHFFFAOYSA-N

Molecular Weight:

371.41688

Exact Mass:

371.42

EC Number:

1592732-453-0

HScode:

29350090

Categories:

Bulk Drug Intermediates

Characteristics

PSA:

129

XLogP3:

-0.5

Density:

1.56

Boiling Point:

707.2

Flash Point:

381.5±35.7 °C

Refractive Index:

1.763

See More Baricitinib Properties 

Hazard Identification

Classification of the substance or mixture

Acute toxicity - Category 4, Oral

GHS label elements, including precautionary statements

Precautionary statement(s)
Pictogram(s)
Signal word	Warning
Hazard statement(s)	H302 Harmful if swallowed
Prevention	P264 Wash ... thoroughly after handling. P270 Do not eat, drink or smoke when using this product.
Response	P301+P317 IF SWALLOWED: Get medical help. P330 Rinse mouth.
Storage	none
Disposal	P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

Other hazards which do not result in classification

no data available

Handling and Storage

Precautions for safe handling

Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

Conditions for safe storage, including any incompatibilities

Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

See More Baricitinib Safety Data Sheet 

Seller Information

Business Type:
Trader

Main Products:
Pharmaceuticals,Peptide,Cosmetics,Nutritional Supplements

Location:
Rm. 803, Tower 4, LOFT49 Creative City Pioneer Zone, No.88 Jiru Rd. Gongshu Dist., Hangzhou, 310015 ZJ, China

Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

Average lead Time:
10

Total Annual Revenue:
$5 million-$10 million

Total Employees:
11-50

Year of Establishment:
2013

Certifications:
Certification Report by Bureau Veritas

About HyperChem

Established in 2013, Hyper Chem has exclusive tie-ups with leading manufacturers, supplying raw materials produced in GMP and ISO 9002 certified facilities, and provides high-quality ingredients and raw materials to meet the needs of a diverse range of pharmaceutical cosmetics ingredients and nootropic supplements companies worldwide.

Our Competitiveness

One-stop supply

Wide Range Of products including pharmaceutical, Cosmetic Ingredients and nootropic supplements

Among all the pharmaceuticals,

90% of them with GMP certificates,

85% of them with DMF files and

50% of them passed FDA approval,

30% get CEP certificate

20% are new R&D products.

Custom Repackaging Service

We can efficiently repackage your material into sample sizes, custom batch-specific sizes, or semi-bulk package sizes according to your specifications. And ensures the product is packaged in a quality-controlled environment and will maintain its integrity throughout every stage of the process.

Quality Control/Quality Assurance

HyperChem is committed to delivering on its promises of top-quality products with verified quality data.

All materials are vigorously inspected by the factory and/or outsourced analytical laboratories to ensure each and every lot meets or exceeds our reference standards.

Trade assurance service with 100% payment protection, It is best achieved by delivering products and services 100% right the first time, on time, every time.

Professional

Transparent Communication

Fast Reaction,

Professional Suggestion

Beyond Expectation.

We have exclusive partnerships with research and production facilities across the country and we offer varied pharmaceutical services in the most cost-efficient way. The production facilities are GMP, WHO-GMP, EU GMP and US FDA approved and are backed by strong regulatory support such as Dossier, DMF, Tech Pack and relevant Stability studies for regulatory filings.

Inquiry History

9 Inquiries

Country	Product	Purchase Quantity	Date Posted
Pakistan	Baricitinib	1 KG	Jun 4, 2025
Thailand	baricitinib	10 G	Sep 27, 2023
Poland	Baricitinib	500 MG	Apr 28, 2026
Bangladesh	Baricitinib	1000 KG	May 6, 2024
India	Baricitinib	50 G	Oct 17, 2025
India	Baricitinib	25.00 G	Oct 14, 2025
Bulgaria	Baricitinib	1 G	Aug 18, 2025
South Korea	Baricitinib	100 G	Mar 27, 2025
Bangladesh	Butyl Acetate	1.00 KG	Nov 11, 2025

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Supplier Name	Details
Baricitinib	Pharmaceutical Grade/99	Echemi Pharmaceutical	Inquiry
Baricitinib CAS1187594-09-7	Pharmaceutical Grade/99	Hangzhou Deli - raw material and API	Inquiry
Baricitinib(INCB28050,LY3009104)	/99	Creative Enzymes	Inquiry
Baricitinib 99% white powder cas1187594-09-7 senwayer	Pharmaceutical Grade/99	Dingwang Technology (Wuhan) Co., Ltd.	Inquiry
1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile	/99.00	HANGZHOU LEAP CHEM CO., LTD.	Inquiry